Literature DB >> 1708734

Effects of nonenzymatic glycosylation of mesangial matrix on proliferation of mesangial cells.

S T Crowley1, M Brownlee, D Edelstein, J A Satriano, T Mori, P C Singhal, D O Schlondorff.   

Abstract

Cross-linking of cell matrix components by nonenzymatic glycosylation may contribute to diabetic glomerulopathy. We examined the effects of modification of matrix by nonenzymatic glycosylation on mesangial cell function. Matrix was generated by growing mesangial cells in tissue culture for 2 wk and removing the cells with a detergent cell-lysis solution. By indirect immunofluorescence and Northern-blot analysis, the remaining matrix contained laminin, fibronectin, and collagens type I and IV. The matrix was modified by incubation for 24 h with 50 mM glycolaldehyde, a highly reactive cross-linking nonenzymatic glycosylation product, or for 2 wk with 200 mM glucose-6-phosphate (G6P). Modification was carried out with or without equimolar aminoguanidine, an inhibitor of cross-link formation. Nonenzymatic glycosylation of the matrix by glycolaldehyde or G6P was confirmed by fluorometry and [14C]G6P incorporation and was prevented by aminoguanidine. [3H]thymidine incorporation for 24 h by mesangial cells plated onto unmodified or modified matrix was then performed. Modification of matrix had no effect on attachment of mesangial cells, determined 4 h after plating. Nonenzymatic glycosylation of matrix by glycolaldehyde or G6P significantly inhibited thymidine incorporation by mesangial cells. This effect was partially reversible by aminoguanidine. Aminoguanidine-modified matrix had no effect on thymidine incorporation. Thymidine-incorporation results were confirmed by direct cell counting. We conclude that modification of matrix by nonenzymatic glycosylation influences growth of mesangial cells, which could contribute to the mesangial abnormalities of diabetic glomerulopathy.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1708734     DOI: 10.2337/diab.40.5.540

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  15 in total

Review 1.  Autocrine and paracrine mechanisms in the early stages of diabetic nephropathy.

Authors:  G Pugliese; F Pricci; G Romeo; G Leto; L Amadio; C Iacobini; U Di Mario
Journal:  J Endocrinol Invest       Date:  1999-10       Impact factor: 4.256

Review 2.  The role of glycation in the pathogenesis of diabetic polyneuropathy.

Authors:  R H King
Journal:  Mol Pathol       Date:  2001-12

3.  Glycated albumin modified by Amadori adducts modulates aortic endothelial cell biology.

Authors:  M P Cohen; E Hud; V Y Wu; F N Ziyadeh
Journal:  Mol Cell Biochem       Date:  1995-02-09       Impact factor: 3.396

4.  Effects of glycated albumin on mesangial cells: evidence for a role in diabetic nephropathy.

Authors:  F N Ziyadeh; M P Cohen
Journal:  Mol Cell Biochem       Date:  1993-08-11       Impact factor: 3.396

5.  Experimental nonenzymatic glycosylation of vitreous collagens occurs by two pathways.

Authors:  J S Pulido
Journal:  Trans Am Ophthalmol Soc       Date:  1996

6.  Effect of glycated collagen on proliferation of human smooth muscle cells in vitro.

Authors:  K Iino; M Yoshinari; M Yamamoto; K Kaku; Y Doi; K Ichikawa; M Iwase; M Fujishima
Journal:  Diabetologia       Date:  1996-07       Impact factor: 10.122

7.  Aminoguanidine treatment reduces the increase in collagen stability of rats with experimental diabetes mellitus.

Authors:  H Oxlund; T T Andreassen
Journal:  Diabetologia       Date:  1992-01       Impact factor: 10.122

8.  Modification of collagen IV by glucose or methylglyoxal alters distinct mesangial cell functions.

Authors:  Ambra Pozzi; Roy Zent; Sergei Chetyrkin; Corina Borza; Nada Bulus; Peale Chuang; Dong Chen; Billy Hudson; Paul Voziyan
Journal:  J Am Soc Nephrol       Date:  2009-07-16       Impact factor: 10.121

9.  Nonenzymatic glycosylation in vitro and in bovine endothelial cells alters basic fibroblast growth factor activity. A model for intracellular glycosylation in diabetes.

Authors:  I Giardino; D Edelstein; M Brownlee
Journal:  J Clin Invest       Date:  1994-07       Impact factor: 14.808

10.  Receptor-specific increase in extracellular matrix production in mouse mesangial cells by advanced glycosylation end products is mediated via platelet-derived growth factor.

Authors:  T Doi; H Vlassara; M Kirstein; Y Yamada; G E Striker; L J Striker
Journal:  Proc Natl Acad Sci U S A       Date:  1992-04-01       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.